TELIX PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.65 AUD | +1.36% |
|
+1.14% | +85.02% |
| 06/06 | Telix Pharmaceuticals Launches $200 Million IPO in US | MT |
| 06/06 | Telix Pharmaceuticals Launches $200 Million US IPO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 415.89Cr | ||||||
| 3.94TCr | ||||||
| 3.85TCr | ||||||
| 3.07TCr | - | |||||
| 2.59TCr | ||||||
| 2.6TCr |
